SCHEMBL18766735

SCHEMBL18766735

C/C=C/c1c(CO)c(F)c(C)c(C(=O)Oc2ccccc2)c1OCc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.37
HPGD P15428 2/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33
MAOB P27338 3/20 0.33
GAA P10253 1/20 0.33
PTGER4 P35408 1/20 0.32
PTGER3 P43115 1/20 0.32
PTGER2 P43116 1/20 0.32
BRD4 O60885 1/20 0.32
CASP3 P42574 1/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32
RAB9A P51151 2/20 0.32
MAPT P10636 1/20 0.32
STAT1 P42224 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12108834 0.91 PTPN1 (0.36) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL18766753 0.90 PTPN1 (0.36) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL18766383 0.87 PTPN1 (0.38) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL114746 0.86 PTPN1 (0.42) PTPN1HPGDLMNAMAOBBRD4
SCHEMBL20370165 0.86 PTPN1 (0.42) PTPN1HPGDLMNAMAOBBRD4
SCHEMBL18523335 0.85 PTPN1 (0.38) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL18511746 0.85 PTPN1 (0.38) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL12109504 0.83 PTPN1 (0.35) PTPN1HPGDLMNAKDM4EALDH1A1
SCHEMBL114772 0.83 PTPN1 (0.40) PTPN1HPGDLMNAMAOBBRD4
SCHEMBL18524982 0.81 PTPN1 (0.41) PTPN1HPGDLMNAMAOBPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170107179-A1 Polycyclic Tetracycline Compounds TETRAPHASE PHARMACEUTICALS, INC. 2017-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170107179-A1 Polycyclic Tetracycline Compounds TET1, TUBA1C, TUBB PTPN1 470/4885HPGD 3299/4885LMNA 2586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.